None
Quote | Akebia Therapeutics Inc. (NASDAQ:AKBA)
Last: | $1.33 |
---|---|
Change Percent: | 1.46% |
Open: | $1.35 |
Close: | $1.33 |
High: | $1.35 |
Low: | $1.31 |
Volume: | 2,537,335 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Akebia Therapeutics Inc. (NASDAQ:AKBA)
2024-04-04 17:56:46 ET Summary Akebia Therapeutics, Inc.'s drug Vadadustat, known as Vafseo, received FDA approval for the treatment of anemia in adults on dialysis, offering improved anemia management for a large patient population. The company's other FDA-approved drug, Auryxia,...
2024-04-02 06:16:12 ET Summary Akebia's Vafseo, a HIF-PH inhibitor for DD-CKD anemia, faces skepticism despite FDA approval due to safety concerns. Market skepticism towards HIF-PH inhibitors, evidenced by GSK's hesitance in Europe, suggests limited adoption for Vafseo. Akebia...
Message Board Posts | Akebia Therapeutics Inc. (NASDAQ:AKBA)
Subject | By | Source | When |
---|---|---|---|
Nice rise from .50s past few weeks. Pump | tw0122 | investorshub | 04/28/2023 11:22:27 AM |
Bought a lot here today. | Afterhoursearnings3 | investorshub | 03/09/2023 7:44:45 PM |
two hedge funds competing to be largest $AKBA | shurtha2000 | investorshub | 03/02/2023 4:04:38 PM |
Nice find G2G. :) | subslover | investorshub | 02/24/2023 12:57:07 PM |
$AKBA 2NEWS 2DAY | TheFinalCD | investorshub | 02/24/2023 12:12:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Akebia Therapeutics Inc. Company Name:
AKBA Stock Symbol:
NASDAQ Market:
Akebia Therapeutics Inc. Website:
2024-03-28 14:00:02 ET Ed Arce from H.C. Wainwright issued a price target of $6.00 for AKBA on 2024-03-28 12:08:00. The adjusted price target was set to $6.00. At the time of the announcement, AKBA was trading at $1.98. The overall price target consensus is at $7.00 with...
Wednesday, the FDA approved Akebia Therapeutics Inc (NASDAQ:AKBA) Vafseo (vadadustat) tablets for anemia due to chronic kidney disease (C...
2024-03-28 13:30:02 ET H.C. Wainwright analyst issues BUY recommendation for AKBA on March 28, 2024 12:08PM ET. The previous analyst recommendation was Buy. AKBA was trading at $2.0093 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...